As one of the most widely studied chemokines, CXCL12 has been reported in both haematological and solid tumours, including acute myeloid leukaemia [20], lymphoma [21], cervical cancer [22], lung cancer [23], colorectal cancer [24], and breast cancer [25]. This evidence concerns the gene CXCL12 and cervical cancer.